BRIEF published on 08/05/2025 at 10:00, 9 months 2 days ago Faits marquants du troisième trimestre 2025 et perspectives pour l'exercice 2025 de SCHOTT Pharma Marge EBITDA Croissance Des Revenus Solutions À Haute Valeur Ajoutée Perspectives Financières T3 2025
BRIEF published on 08/05/2025 at 09:58, 9 months 2 days ago SCHOTT Pharma Updates FY 2025 Revenue and EBITDA Guidance Financial Results Revenue Growth EBITDA Margin SCHOTT Pharma FY 2025 Guidance
BRIEF published on 08/05/2025 at 09:58, 9 months 2 days ago SCHOTT Pharma met à jour ses prévisions de chiffre d'affaires et d'EBITDA pour l'exercice 2025 Résultats Financiers SCHOTT Pharma Marge EBITDA Croissance Des Revenus Orientations Pour L'exercice 2025
BRIEF published on 08/05/2025 at 09:46, 9 months 2 days ago État du capital et des droits de vote de bioMérieux en juillet 2025 Droits De Vote Capital Social BioMérieux AMF Juillet 2025
BRIEF published on 08/05/2025 at 09:46, 9 months 2 days ago Status of bioMérieux's capital and voting rights in July 2025 Share Capital Voting Rights BioMérieux AMF July 2025
BRIEF published on 08/05/2025 at 09:35, 9 months 2 days ago PFISTERER Invests in High-Voltage Laboratory to Enter HVDC Market Energy Infrastructure PFISTERER High-voltage Laboratory HVDC Market Silicone Expertise
BRIEF published on 08/05/2025 at 09:35, 9 months 2 days ago PFISTERER investit dans un laboratoire haute tension pour entrer sur le marché du HVDC Infrastructures Énergétiques PFISTERER Laboratoire Haute Tension Marché HVDC Expertise En Silicone
BRIEF published on 08/05/2025 at 09:31, 9 months 2 days ago Courtois S.A. : Décomposition des Droits de Vote au 31 juillet 2025 Droits De Vote Capital Social Actions En Circulation Courtois S.A. Obligations Statutaires
BRIEF published on 08/05/2025 at 09:31, 9 months 2 days ago Courtois SA: Breakdown of Voting Rights as of July 31, 2025 Share Capital Voting Rights Courtois SA Shares Outstanding Statutory Obligations
BRIEF published on 08/05/2025 at 09:10, 9 months 2 days ago BioNxt Solutions Advances Patent Protection for MS Treatment Multiple Sclerosis Drug Delivery Technology Patent Protection BioNxt Solutions Sublingual Cladribine
Published on 05/07/2026 at 14:35, 18 minutes ago Worksport (NASDAQ: WKSP) Announces Q1 2026 Earnings Call Date and Launch of Investor Townhall Series
Published on 05/07/2026 at 14:30, 23 minutes ago Rio Grande Resources Announces Results of First Annual General Meeting and Re-Appointments
Published on 05/07/2026 at 14:30, 23 minutes ago Loar Holdings Inc. Reports Q1 2026 Record Results and Upward Revision to 2026 Outlook
Published on 05/07/2026 at 14:00, 53 minutes ago Adcore to Publish First Quarter 2026 Results on May 14, 2026
Published on 05/07/2026 at 14:00, 53 minutes ago Metallic Minerals Announces Option Agreement with Argyle Resources on McKay Hill Property, Yukon
Published on 05/07/2026 at 14:30, 23 minutes ago More charging power than the grid connection can provide: Battery-buffered microgrid unlocks new potential for fast charging
Published on 05/07/2026 at 14:05, 48 minutes ago Addepar Introduces ADX, Enabling Data Activation and AI at Scale
Published on 05/07/2026 at 14:02, 50 minutes ago Genel Energy PLC: Results of Annual General Meeting 7 May 2026
Published on 05/07/2026 at 07:43, 7 hours 10 minutes ago ENGIE - Information Financière 1er trimestre 2026
Published on 05/06/2026 at 18:00, 20 hours 53 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 20 hours 53 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 20 hours 53 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
